Home / Business and Economy / Pershing Square Bets Big on Eye Care Giant Alcon
Pershing Square Bets Big on Eye Care Giant Alcon
19 Aug
Summary
- Pershing Square initiated a new position in Alcon Inc. during Q2 2026.
- Alcon is a global leader in ophthalmology with strong positions in surgical vision.
- The company benefits from demographic trends and a recurring revenue model.
Pershing Square Holdings has disclosed a significant new investment in Alcon Inc. (NYSE:ALC) in its second quarter 2026 investor letter. Alcon, a Swiss-based company, stands as the world's leading ophthalmology firm, holding dominant positions in surgical vision and significant shares in vision care and contact lenses.
The company's strategic advantage stems from its robust installed base of surgical equipment, generating high-margin recurring revenue from consumables. This model funds its extensive research and commercial operations, driving innovation.
Alcon is poised to benefit from favorable long-term trends, including an aging global population, rising incomes, and expanded healthcare access. These factors are anticipated to support mid-single-digit market growth in the coming years.
This investment in Alcon Inc. adds to Pershing Square's portfolio of publicly traded assets, which constitute 98% of its capital structure. The firm's strategy involves acquiring quality companies at attractive valuations, aiming for substantial EPS growth.
